Log In
Print this Print this

GVAX Pancreas cancer vaccine

Also known as: BioSante vaccine for pancreatic cancer

  Manage Alerts
Collapse Summary General Information
Company Aduro Biotech Inc.
DescriptionAllogeneic cancer vaccine engineered to secrete GM-CSF
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationPancreatic cancer
Indication DetailsTreat advanced pancreatic cancer; Treat metastatic pancreatic cancer; Treat operable pancreatic cancer; Treat pancreatic cancer
Regulatory Designation U.S. - Breakthrough Therapy (Treat pancreatic cancer);
U.S. - Orphan Drug (Treat pancreatic cancer);
EU - Orphan Drug (Treat advanced pancreatic cancer)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today